These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15155480)

  • 1. Pfizer pleads guilty, but drug sales continue to soar.
    Lenzer J
    BMJ; 2004 May; 328(7450):1217. PubMed ID: 15155480
    [No Abstract]   [Full Text] [Related]  

  • 2. Doctor explains why he blew the whistle.
    Petersen M
    N Y Times Web; 2003 Mar; ():C1, C2. PubMed ID: 12812161
    [No Abstract]   [Full Text] [Related]  

  • 3. Court papers suggest scale of drug's use: lawsuit says doctors were paid endorsers.
    Petersen M
    N Y Times Web; 2003 May; ():C1, C2. PubMed ID: 12812176
    [No Abstract]   [Full Text] [Related]  

  • 4. Pfizer to pay $430 million over promoting drug to doctors.
    Harris G
    N Y Times Web; 2004 May; ():C6. PubMed ID: 15290803
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug maker to pay $430 million in fines, civil damages.
    FDA Consum; 2004; 38(4):36-7. PubMed ID: 15346583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neurontin legacy--marketing through misinformation and manipulation.
    Landefeld CS; Steinman MA
    N Engl J Med; 2009 Jan; 360(2):103-6. PubMed ID: 19129523
    [No Abstract]   [Full Text] [Related]  

  • 7. Pfizer versus Kaiser: insurers want their day in court.
    Silverman E
    BMJ; 2013 Jun; 346():f3738. PubMed ID: 23760967
    [No Abstract]   [Full Text] [Related]  

  • 8. Warner-Lambert found guilty of promoting neurontin off label.
    Larkin M
    Lancet Neurol; 2004 Jul; 3(7):387. PubMed ID: 15228033
    [No Abstract]   [Full Text] [Related]  

  • 9. Confounding factors in off-label drug use.
    Greenberg PE; Pike C; Sisitsky T
    Health Aff (Millwood); 2012 Feb; 31(2):460; author reply 460. PubMed ID: 22323178
    [No Abstract]   [Full Text] [Related]  

  • 10. Dicing with death : there's a good chance that the pills your doctor prescribed will do you no good and might even harm you.
    Muir H
    New Sci; 2006 Jul 29-Aug 4; 191(2562):38-41. PubMed ID: 17115486
    [No Abstract]   [Full Text] [Related]  

  • 11. False Claims Act prosecution did not deter off-label drug use in the case of neurontin.
    Kesselheim AS; Darby D; Studdert DM; Glynn R; Levin R; Avorn J
    Health Aff (Millwood); 2011 Dec; 30(12):2318-27. PubMed ID: 22147859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of drug trials can mystify doctors through omission: some professional groups demand public listing of all test outcomes.
    Meier B
    N Y Times Web; 2004 Jul; ():C1, C3. PubMed ID: 15290807
    [No Abstract]   [Full Text] [Related]  

  • 13. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 14. The truth is out there.
    Lancet Neurol; 2003 May; 2(5):261. PubMed ID: 12849163
    [No Abstract]   [Full Text] [Related]  

  • 15. Punishing health care fraud--is the GSK settlement sufficient?
    Outterson K
    N Engl J Med; 2012 Sep; 367(12):1082-5. PubMed ID: 22970920
    [No Abstract]   [Full Text] [Related]  

  • 16. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2009 Apr; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract]   [Full Text] [Related]  

  • 17. Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.
    Chace MJ; Zhang F; Fullerton CA; Huskamp HA; Gilden D; Soumerai SB
    J Clin Psychiatry; 2012 Nov; 73(11):1388-94. PubMed ID: 23146199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The professional society circus.
    Kassirer JP
    J Public Health Policy; 2005 Dec; 26(4):400-3. PubMed ID: 16392739
    [No Abstract]   [Full Text] [Related]  

  • 19. Doctor sues company over unethical marketing.
    Charatan F
    BMJ; 2002 May; 324(7348):1234. PubMed ID: 12028969
    [No Abstract]   [Full Text] [Related]  

  • 20. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.